Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Adrenergic signaling in cardiomyocytes
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
2 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Adrenergic signaling in cardiomyocytes
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
3 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Adrenergic signaling in cardiomyocytes
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
4 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Adrenergic signaling in cardiomyocytes
| Azilsartan medoxomil | 066 [1] 66 💬4. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
5 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Adrenergic signaling in cardiomyocytes
| Azilsartan medoxomil | 066 [1] 66 💬4. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
6 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Adrenergic signaling in cardiomyocytes
| Azilsartan medoxomil | 066 [1] 66 💬4. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
7 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Adrenergic signaling in cardiomyocytes
| Buloxibutid | 085 [1] 85 💬7. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
8 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Adrenergic signaling in cardiomyocytes
| Buloxibutid | 085 [1] 85 💬7. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
9 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Adrenergic signaling in cardiomyocytes
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
10 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Adrenergic signaling in cardiomyocytes
| Irbesartan | 066 [4] 66, 167, 168, 222 💬10. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
11 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬11. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
12 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬11. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
13 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Adrenergic signaling in cardiomyocytes
| Sparsentan | 066 [3] 66, 218, 222 💬13. Adrenergic signaling in cardiomyocytes |
||||||||||||||||||||||||||||||||||||||||||||||
14 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Adrenergic signaling in cardiomyocytes
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
15 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Adrenergic signaling in cardiomyocytes
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬15. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
16 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬AGE-RAGE signaling pathway in diabetic complications
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬16. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
17 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬AGE-RAGE signaling pathway in diabetic complications
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬16. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
18 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬AGE-RAGE signaling pathway in diabetic complications
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬16. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
19 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬AGE-RAGE signaling pathway in diabetic complications
| Azilsartan medoxomil | 066 [1] 66 💬19. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
20 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬AGE-RAGE signaling pathway in diabetic complications
| Azilsartan medoxomil | 066 [1] 66 💬19. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
21 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬AGE-RAGE signaling pathway in diabetic complications
| Azilsartan medoxomil | 066 [1] 66 💬19. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
22 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬AGE-RAGE signaling pathway in diabetic complications
| Buloxibutid | 085 [1] 85 💬22. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
23 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬AGE-RAGE signaling pathway in diabetic complications
| Buloxibutid | 085 [1] 85 💬22. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
24 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬AGE-RAGE signaling pathway in diabetic complications
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
25 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬AGE-RAGE signaling pathway in diabetic complications
| Irbesartan | 066 [4] 66, 167, 168, 222 💬25. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
26 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬26. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
27 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬26. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
28 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬AGE-RAGE signaling pathway in diabetic complications
| Sparsentan | 066 [3] 66, 218, 222 💬28. AGE-RAGE signaling pathway in diabetic complications |
||||||||||||||||||||||||||||||||||||||||||||||
29 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬AGE-RAGE signaling pathway in diabetic complications
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
30 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬AGE-RAGE signaling pathway in diabetic complications
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬30. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
31 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Aldosterone synthesis and secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬31. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
32 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Aldosterone synthesis and secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬31. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
33 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Aldosterone synthesis and secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬31. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
34 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Aldosterone synthesis and secretion
| Azilsartan medoxomil | 066 [1] 66 💬34. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
35 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Aldosterone synthesis and secretion
| Azilsartan medoxomil | 066 [1] 66 💬34. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
36 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Aldosterone synthesis and secretion
| Azilsartan medoxomil | 066 [1] 66 💬34. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
37 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Aldosterone synthesis and secretion
| Buloxibutid | 085 [1] 85 💬37. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
38 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Aldosterone synthesis and secretion
| Buloxibutid | 085 [1] 85 💬37. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
39 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Aldosterone synthesis and secretion
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
40 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Aldosterone synthesis and secretion
| Irbesartan | 066 [4] 66, 167, 168, 222 💬40. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
41 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Aldosterone synthesis and secretion
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬41. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
42 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Aldosterone synthesis and secretion
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬41. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
43 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Aldosterone synthesis and secretion
| Sparsentan | 066 [3] 66, 218, 222 💬43. Aldosterone synthesis and secretion |
||||||||||||||||||||||||||||||||||||||||||||||
44 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Aldosterone synthesis and secretion
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
45 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Aldosterone synthesis and secretion
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬45. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
46 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Apelin signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬46. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
47 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Apelin signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬46. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
48 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Apelin signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬46. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
49 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Apelin signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬49. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
50 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Apelin signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬49. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
51 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Apelin signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬49. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
52 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Apelin signaling pathway
| Buloxibutid | 085 [1] 85 💬52. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
53 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Apelin signaling pathway
| Buloxibutid | 085 [1] 85 💬52. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
54 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Apelin signaling pathway
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
55 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Apelin signaling pathway
| Irbesartan | 066 [4] 66, 167, 168, 222 💬55. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
56 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Apelin signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬56. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
57 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Apelin signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬56. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
58 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Apelin signaling pathway
| Sparsentan | 066 [3] 66, 218, 222 💬58. Apelin signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||
59 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Apelin signaling pathway
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
60 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Apelin signaling pathway
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬60. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
61 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Calcium signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬61. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
62 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Calcium signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬61. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
63 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Calcium signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬61. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
64 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Calcium signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬64. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
65 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Calcium signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬64. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
66 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Calcium signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬64. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
67 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Calcium signaling pathway
| Buloxibutid | 085 [1] 85 💬67. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
68 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Calcium signaling pathway
| Buloxibutid | 085 [1] 85 💬67. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
69 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Calcium signaling pathway
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
70 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Calcium signaling pathway
| Irbesartan | 066 [4] 66, 167, 168, 222 💬70. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
71 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Calcium signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬71. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
72 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Calcium signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬71. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
73 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Calcium signaling pathway
| Sparsentan | 066 [3] 66, 218, 222 💬73. Calcium signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||
74 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Calcium signaling pathway
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
75 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Calcium signaling pathway
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬75. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
76 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬cGMP-PKG signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬76. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
77 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬cGMP-PKG signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬76. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
78 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬cGMP-PKG signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬76. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
79 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬cGMP-PKG signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬79. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
80 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬cGMP-PKG signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬79. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
81 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬cGMP-PKG signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬79. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
82 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬cGMP-PKG signaling pathway
| Buloxibutid | 085 [1] 85 💬82. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
83 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬cGMP-PKG signaling pathway
| Buloxibutid | 085 [1] 85 💬82. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
84 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬cGMP-PKG signaling pathway
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
85 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬cGMP-PKG signaling pathway
| Irbesartan | 066 [4] 66, 167, 168, 222 💬85. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
86 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬cGMP-PKG signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬86. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
87 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬cGMP-PKG signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬86. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
88 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬cGMP-PKG signaling pathway
| Sparsentan | 066 [3] 66, 218, 222 💬88. cGMP-PKG signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||
89 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬cGMP-PKG signaling pathway
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
90 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬cGMP-PKG signaling pathway
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬90. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
91 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Coronavirus disease - COVID-19
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬91. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
92 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Coronavirus disease - COVID-19
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬91. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
93 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Coronavirus disease - COVID-19
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬91. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
94 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Coronavirus disease - COVID-19
| Azilsartan medoxomil | 066 [1] 66 💬94. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
95 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Coronavirus disease - COVID-19
| Azilsartan medoxomil | 066 [1] 66 💬94. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
96 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Coronavirus disease - COVID-19
| Azilsartan medoxomil | 066 [1] 66 💬94. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
97 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Coronavirus disease - COVID-19
| Buloxibutid | 085 [1] 85 💬97. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
98 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Coronavirus disease - COVID-19
| Buloxibutid | 085 [1] 85 💬97. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
99 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Coronavirus disease - COVID-19
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
100 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Coronavirus disease - COVID-19
| Irbesartan | 066 [4] 66, 167, 168, 222 💬100. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
101 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Coronavirus disease - COVID-19
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬101. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
102 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Coronavirus disease - COVID-19
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬101. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
103 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Coronavirus disease - COVID-19
| Sparsentan | 066 [3] 66, 218, 222 💬103. Coronavirus disease - COVID-19 |
||||||||||||||||||||||||||||||||||||||||||||||
104 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Coronavirus disease - COVID-19
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
105 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Coronavirus disease - COVID-19
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬105. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
106 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Cortisol synthesis and secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬106. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
107 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Cortisol synthesis and secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬106. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
108 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Cortisol synthesis and secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬106. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
109 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Cortisol synthesis and secretion
| Azilsartan medoxomil | 066 [1] 66 💬109. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
110 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Cortisol synthesis and secretion
| Azilsartan medoxomil | 066 [1] 66 💬109. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
111 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Cortisol synthesis and secretion
| Azilsartan medoxomil | 066 [1] 66 💬109. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
112 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Cortisol synthesis and secretion
| Buloxibutid | 085 [1] 85 💬112. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
113 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Cortisol synthesis and secretion
| Buloxibutid | 085 [1] 85 💬112. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
114 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Cortisol synthesis and secretion
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
115 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Cortisol synthesis and secretion
| Irbesartan | 066 [4] 66, 167, 168, 222 💬115. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
116 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Cortisol synthesis and secretion
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬116. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
117 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Cortisol synthesis and secretion
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬116. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
118 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Cortisol synthesis and secretion
| Sparsentan | 066 [3] 66, 218, 222 💬118. Cortisol synthesis and secretion |
||||||||||||||||||||||||||||||||||||||||||||||
119 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Cortisol synthesis and secretion
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
120 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Cortisol synthesis and secretion
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬120. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
121 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Cushing syndrome
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬121. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
122 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Cushing syndrome
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬121. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
123 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Cushing syndrome
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬121. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
124 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Cushing syndrome
| Azilsartan medoxomil | 066 [1] 66 💬124. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
125 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Cushing syndrome
| Azilsartan medoxomil | 066 [1] 66 💬124. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
126 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Cushing syndrome
| Azilsartan medoxomil | 066 [1] 66 💬124. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
127 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Cushing syndrome
| Buloxibutid | 085 [1] 85 💬127. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
128 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Cushing syndrome
| Buloxibutid | 085 [1] 85 💬127. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
129 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Cushing syndrome
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
130 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Cushing syndrome
| Irbesartan | 066 [4] 66, 167, 168, 222 💬130. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
131 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Cushing syndrome
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬131. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
132 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Cushing syndrome
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬131. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
133 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Cushing syndrome
| Sparsentan | 066 [3] 66, 218, 222 💬133. Cushing syndrome |
||||||||||||||||||||||||||||||||||||||||||||||
134 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Cushing syndrome
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
135 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Cushing syndrome
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬135. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
136 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Diabetic cardiomyopathy
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬136. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
137 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Diabetic cardiomyopathy
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬136. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
138 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Diabetic cardiomyopathy
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬136. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
139 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Diabetic cardiomyopathy
| Azilsartan medoxomil | 066 [1] 66 💬139. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
140 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Diabetic cardiomyopathy
| Azilsartan medoxomil | 066 [1] 66 💬139. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
141 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Diabetic cardiomyopathy
| Azilsartan medoxomil | 066 [1] 66 💬139. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
142 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Diabetic cardiomyopathy
| Buloxibutid | 085 [1] 85 💬142. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
143 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Diabetic cardiomyopathy
| Buloxibutid | 085 [1] 85 💬142. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
144 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Diabetic cardiomyopathy
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
145 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Diabetic cardiomyopathy
| Irbesartan | 066 [4] 66, 167, 168, 222 💬145. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
146 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Diabetic cardiomyopathy
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬146. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
147 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Diabetic cardiomyopathy
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬146. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
148 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Diabetic cardiomyopathy
| Sparsentan | 066 [3] 66, 218, 222 💬148. Diabetic cardiomyopathy |
||||||||||||||||||||||||||||||||||||||||||||||
149 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Diabetic cardiomyopathy
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
150 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Diabetic cardiomyopathy
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬150. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
151 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Hormone signaling
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬151. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
152 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Hormone signaling
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬151. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
153 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Hormone signaling
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬151. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
154 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Hormone signaling
| Azilsartan medoxomil | 066 [1] 66 💬154. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
155 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Hormone signaling
| Azilsartan medoxomil | 066 [1] 66 💬154. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
156 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Hormone signaling
| Azilsartan medoxomil | 066 [1] 66 💬154. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
157 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Hormone signaling
| Buloxibutid | 085 [1] 85 💬157. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
158 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Hormone signaling
| Buloxibutid | 085 [1] 85 💬157. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
159 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Hormone signaling
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
160 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Hormone signaling
| Irbesartan | 066 [4] 66, 167, 168, 222 💬160. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
161 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Hormone signaling
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬161. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
162 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Hormone signaling
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬161. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
163 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Hormone signaling
| Sparsentan | 066 [3] 66, 218, 222 💬163. Hormone signaling |
||||||||||||||||||||||||||||||||||||||||||||||
164 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Hormone signaling
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
165 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Hormone signaling
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬165. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
166 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Neuroactive ligand-receptor interaction
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬166. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
167 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Neuroactive ligand-receptor interaction
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬166. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
168 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Neuroactive ligand-receptor interaction
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬166. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
169 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Neuroactive ligand-receptor interaction
| Azilsartan medoxomil | 066 [1] 66 💬169. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
170 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Neuroactive ligand-receptor interaction
| Azilsartan medoxomil | 066 [1] 66 💬169. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
171 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Neuroactive ligand-receptor interaction
| Azilsartan medoxomil | 066 [1] 66 💬169. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
172 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Neuroactive ligand-receptor interaction
| Buloxibutid | 085 [1] 85 💬172. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
173 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Neuroactive ligand-receptor interaction
| Buloxibutid | 085 [1] 85 💬172. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
174 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Neuroactive ligand-receptor interaction
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
175 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Neuroactive ligand-receptor interaction
| Irbesartan | 066 [4] 66, 167, 168, 222 💬175. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
176 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Neuroactive ligand-receptor interaction
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬176. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
177 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Neuroactive ligand-receptor interaction
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬176. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
178 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Neuroactive ligand-receptor interaction
| Sparsentan | 066 [3] 66, 218, 222 💬178. Neuroactive ligand-receptor interaction |
||||||||||||||||||||||||||||||||||||||||||||||
179 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Neuroactive ligand-receptor interaction
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
180 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Neuroactive ligand-receptor interaction
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬180. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
181 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Pathways in cancer
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬181. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
182 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Pathways in cancer
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬181. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
183 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Pathways in cancer
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬181. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
184 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Pathways in cancer
| Azilsartan medoxomil | 066 [1] 66 💬184. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
185 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Pathways in cancer
| Azilsartan medoxomil | 066 [1] 66 💬184. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
186 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Pathways in cancer
| Azilsartan medoxomil | 066 [1] 66 💬184. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
187 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Pathways in cancer
| Buloxibutid | 085 [1] 85 💬187. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
188 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Pathways in cancer
| Buloxibutid | 085 [1] 85 💬187. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
189 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Pathways in cancer
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
190 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Pathways in cancer
| Irbesartan | 066 [4] 66, 167, 168, 222 💬190. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
191 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Pathways in cancer
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬191. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
192 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Pathways in cancer
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬191. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
193 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Pathways in cancer
| Sparsentan | 066 [3] 66, 218, 222 💬193. Pathways in cancer |
||||||||||||||||||||||||||||||||||||||||||||||
194 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Pathways in cancer
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
195 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Pathways in cancer
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬195. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
196 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Phospholipase D signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬196. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
197 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Phospholipase D signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬196. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
198 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Phospholipase D signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬196. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
199 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Phospholipase D signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬199. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
200 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Phospholipase D signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬199. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
201 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Phospholipase D signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬199. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
202 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Phospholipase D signaling pathway
| Buloxibutid | 085 [1] 85 💬202. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
203 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Phospholipase D signaling pathway
| Buloxibutid | 085 [1] 85 💬202. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
204 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Phospholipase D signaling pathway
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
205 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Phospholipase D signaling pathway
| Irbesartan | 066 [4] 66, 167, 168, 222 💬205. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
206 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Phospholipase D signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬206. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
207 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Phospholipase D signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬206. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
208 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Phospholipase D signaling pathway
| Sparsentan | 066 [3] 66, 218, 222 💬208. Phospholipase D signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||
209 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Phospholipase D signaling pathway
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
210 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Phospholipase D signaling pathway
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬210. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
211 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Renin secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬211. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
212 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Renin secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬211. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
213 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Renin secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬211. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
214 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Renin secretion
| Azilsartan medoxomil | 066 [1] 66 💬214. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
215 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Renin secretion
| Azilsartan medoxomil | 066 [1] 66 💬214. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
216 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Renin secretion
| Azilsartan medoxomil | 066 [1] 66 💬214. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
217 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Renin secretion
| Buloxibutid | 085 [1] 85 💬217. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
218 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Renin secretion
| Buloxibutid | 085 [1] 85 💬217. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
219 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Renin secretion
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
220 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Renin secretion
| Irbesartan | 066 [4] 66, 167, 168, 222 💬220. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
221 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Renin secretion
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬221. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
222 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Renin secretion
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬221. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
223 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Renin secretion
| Sparsentan | 066 [3] 66, 218, 222 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
224 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Renin secretion
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
225 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Renin secretion
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬225. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
226 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Renin-angiotensin system
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬226. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
227 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Renin-angiotensin system
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬226. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
228 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Renin-angiotensin system
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬226. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
229 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Renin-angiotensin system
| Azilsartan medoxomil | 066 [1] 66 💬229. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
230 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Renin-angiotensin system
| Azilsartan medoxomil | 066 [1] 66 💬229. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
231 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Renin-angiotensin system
| Azilsartan medoxomil | 066 [1] 66 💬229. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
232 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Renin-angiotensin system
| Buloxibutid | 085 [1] 85 💬232. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
233 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Renin-angiotensin system
| Buloxibutid | 085 [1] 85 💬232. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
234 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Renin-angiotensin system
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
235 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Renin-angiotensin system
| Irbesartan | 066 [4] 66, 167, 168, 222 💬235. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
236 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Renin-angiotensin system
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬236. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
237 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Renin-angiotensin system
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬236. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
238 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Renin-angiotensin system
| Sparsentan | 066 [3] 66, 218, 222 💬238. Renin-angiotensin system |
||||||||||||||||||||||||||||||||||||||||||||||
239 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Renin-angiotensin system
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
240 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Renin-angiotensin system
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬240. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
241 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Vascular smooth muscle contraction
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬241. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
242 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Vascular smooth muscle contraction
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬241. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
243 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Vascular smooth muscle contraction
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬241. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
244 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Vascular smooth muscle contraction
| Azilsartan medoxomil | 066 [1] 66 💬244. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
245 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Vascular smooth muscle contraction
| Azilsartan medoxomil | 066 [1] 66 💬244. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
246 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Vascular smooth muscle contraction
| Azilsartan medoxomil | 066 [1] 66 💬244. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
247 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Vascular smooth muscle contraction
| Buloxibutid | 085 [1] 85 💬247. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
248 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Vascular smooth muscle contraction
| Buloxibutid | 085 [1] 85 💬247. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
249 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Vascular smooth muscle contraction
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
250 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Vascular smooth muscle contraction
| Irbesartan | 066 [4] 66, 167, 168, 222 💬250. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
251 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Vascular smooth muscle contraction
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬251. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
252 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Vascular smooth muscle contraction
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬251. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
253 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Vascular smooth muscle contraction
| Sparsentan | 066 [3] 66, 218, 222 💬253. Vascular smooth muscle contraction |
||||||||||||||||||||||||||||||||||||||||||||||
254 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Vascular smooth muscle contraction
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
255 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Vascular smooth muscle contraction
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬255. Vascular smooth muscle contraction
|
Adrenergic signaling in cardiomyocytes
1 gene, 9 drugs (DrugBank) and 26 diseases
AGE-RAGE signaling pathway in diabetic complications
1 gene, 9 drugs (DrugBank) and 26 diseases
Aldosterone synthesis and secretion
1 gene, 9 drugs (DrugBank) and 26 diseases
Apelin signaling pathway
1 gene, 9 drugs (DrugBank) and 26 diseases
Calcium signaling pathway
1 gene, 9 drugs (DrugBank) and 26 diseases
cGMP-PKG signaling pathway
1 gene, 9 drugs (DrugBank) and 26 diseases
Coronavirus disease - COVID-19
1 gene, 9 drugs (DrugBank) and 26 diseases
Cortisol synthesis and secretion
1 gene, 9 drugs (DrugBank) and 26 diseases
Cushing syndrome
1 gene, 9 drugs (DrugBank) and 26 diseases
Diabetic cardiomyopathy
1 gene, 9 drugs (DrugBank) and 26 diseases
Hormone signaling
1 gene, 9 drugs (DrugBank) and 26 diseases
Neuroactive ligand-receptor interaction
1 gene, 9 drugs (DrugBank) and 26 diseases
Pathways in cancer
1 gene, 9 drugs (DrugBank) and 26 diseases
Phospholipase D signaling pathway
1 gene, 9 drugs (DrugBank) and 26 diseases
Renin secretion
1 gene, 9 drugs (DrugBank) and 26 diseases
Renin-angiotensin system
1 gene, 9 drugs (DrugBank) and 26 diseases
Vascular smooth muscle contraction
1 gene, 9 drugs (DrugBank) and 26 diseases